Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ultrastructure of telangiectatic osteosarcoma.

A Roessner, H P Hobik, M Immenkamp

    Journal of Cancer Research and Clinical Oncology
    |October 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Telangiectatic osteosarcoma (TOS) shows a poorer prognosis. Electron microscopy revealed angiosarcomatous components in TOS, suggesting derivation from multipotent mesenchymal cells with diverse differentiation potential.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Bone tumours].

    Der Pathologe·2020
    Same author

    [Narrow band imaging for evaluation of laryngeal mucosal lesions].

    HNO·2017
    Same author

    Articulating polymethylmethacrylate (PMMA) spacers may have an immunomodulating effect on synovial tissue.

    The bone & joint journal·2016
    Same author

    [Inaugural speech of the congress president of the German Society of Pathology at the 98th annual congress].

    Der Pathologe·2014
    Same author

    [98th Annual Conference of the German Society for Pathology : Berlin, 12-15 June 2014].

    Der Pathologe·2014
    Same author

    BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

    Journal of cancer research and clinical oncology·2014

    Area of Science:

    • Oncology
    • Bone Tumors
    • Histopathology

    Background:

    • Telangiectatic osteosarcoma (TOS) is associated with a poorer prognosis compared to other osteosarcomas.
    • Understanding the histogenesis of TOS is crucial for improving patient outcomes.